Historical record - last NADAC effective date: 2/22/2017
Product Information
SIMVASTATIN 5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0513 per EA under NDC 65862005030. Its NADAC has been published 170 times since Nov 28, 2013.
FDA first approved this application on Dec 20, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862005030
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/22/2017
Active Ingredients
SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA077691FDA Approved
12/20/2006
TE Code
AB
On Market Since
12/20/2006
Pharmacological Classes
Price Statistics
The NADAC for SIMVASTATIN 5 MG TABLET has been published 170 times since Nov 28, 2013, and over the history we have for it it has risen 23.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0513 per EA |
|---|---|
| All-time high | $0.0597 (Oct 12, 2016) |
| All-time low | $0.0414 (Nov 28, 2013) |
| Median price | $0.0449 |
| Average price | $0.0469 |
| Largest weekly change | +22.6% (Jun 22, 2016) |
| Weeks tracked | 170 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+23.8%
Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SIMVASTATIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIMVASTATIN 5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0513 per EA (NDC 65862005030), effective Feb 22, 2017.
How has the price of SIMVASTATIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIMVASTATIN 5 MG TABLET has risen 23.8%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SIMVASTATIN 5 MG TABLET?
Since Nov 28, 2013, the NADAC for SIMVASTATIN 5 MG TABLET has ranged from a low of $0.0414 (Nov 28, 2013) to a high of $0.0597 (Oct 12, 2016), with a median of $0.0449 per EA.
Are there cheaper alternatives to SIMVASTATIN 5 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SIMVASTATIN 5 MG TABLET, is $0.0288 per EA — about 44% below SIMVASTATIN 5 MG TABLET.
Who manufactures SIMVASTATIN 5 MG TABLET?
SIMVASTATIN 5 MG TABLET (NDC 65862005030) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.